BC Week In Review | Oct 27, 1997
Clinical News

LXR regulatory update

LXR received U.S. Patents Nos. 5,652,210 and 5,663,070 relating to the Fas delta gene and its encoded protein, which is the naturally occurring form of the Fas receptor involved in signaling cell death. The first...
Items per page:
1 - 1 of 1